Skip to main content
. 2023 Jul 4;8(4):101593. doi: 10.1016/j.esmoop.2023.101593

Figure 1.

Figure 1

Flow diagram describing the selection of indications included in the study. Notes: See Table A.2 in the Supplementary Appendix, available at https://doi.org/10.1016/j.esmoop.2023.101593 for the full list of included indications. EMA, European Medicines Agency; ESMO-MCBS, European Society for Medical Oncology Magnitude of Clinical Benefit Scale.